European Heart Journal review probes unexplained semaglutide mechanisms
Verma, Guzik, Cosentino and colleagues survey what remains unknown about how the GLP-1 agonist produces cardiovascular benefit.
PR
By Priya Raman · Science Reporter
Sep 22 20:00 ETSource: European heart journal
The wire
- 01A review in European Heart Journal, published 23 September 2026, examines gaps in the understanding of semaglutide's mechanisms of action.
- 02Clinicians prescribing semaglutide for cardiometabolic indications have argued over how much benefit is weight-independent; the review addresses that question directly.
- 03It is a narrative review rather than new trial data, and the abstract text available gives no specific conclusions.
From the source
Read at pubmed.ncbi.nlm.nih.govSemaglutide mechanisms of action: the missing pieces
European heart journal · 2026 Sep 23 · Verma S, Guzik TJ, Cosentino F et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42777686/
